(S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid CAS 85977-52-2 Purity ≥99.0% e.e.≥99.0% Palonosetron Hydrochloride Intermediate Factory

Short Description:

Chemical Name: (S)-1,2,3,4-1-Tetrahydro-Naphthoic Acid 

CAS: 85977-52-2

Appearance: White or Almost White Crystalline Powder

Purity: ≥99.0%

Enantimoer Excess: e.e≥99.0% 

Intermediate of Palonosetron Hydrochloride (CAS: 135729-62-3) in the treatment of CINV

E-mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid
Synonyms (1S)-1,2,3,4-Tetrahydronaphthalene-1-Carboxylic acid
CAS Number 85977-52-2
CAT Number RF-CC111
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C11H12O2
Molecular Weight 176.21
Density 1.186g/cm3
Melting Point 54.0~56.0℃ 
Boiling Point 342.7°C at 760 mmHg
Refractive Index 1.576
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White or Almost White Crystalline Powder
Chemical Purity ≥99.0%
Enantimoer Excess e.e. ≥99.0%
Isomer Impurity ≤1.0%
Loss on Drying ≤0.50%
Relate Substance ≤1.0%
Moisture (K.F) ≤1.0%
Specific Rotation [α]D20 -59.0°~ -63.0°(C=0.3 in Benzence)
Heavy Metals ≤20ppm
Storage 5-8℃ Airtightness
Test Standard Enterprise Standard
Usage Palonosetron Hydrochloride (CAS: 135729-62-3) Intermediates 

(S)-1,2,3,4-tetrahydro-1-Naphthoic Acid CAS: 85977-52-2 Route of Synthesis 

85977-52-2

Package & Storage:

Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

2

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid (CAS: 85977-52-2) with high quality. It is an intermediate typically in the synthesis of Palonosetron Hydrochloride (CAS: 135729-62-3).

Palonosetron Hydrochloride (CAS: 135729-62-3) is a novel 5-HT3 receptor antagonist launched as an injectable agent for the prevention of acute and delayed nausea and vomiting associated with cancer chemotherapy. It has a much longer half-life (~40 h) than the other currently available 5-HT3 antagonists, which provides efficacy advantages in the prevention of delayed nausea and vomiting that typically occurs after 24 h and up to six days post chemotherapy administration. With 1,2,3,4-tetrahydro-1-Naphthoic Acid as the starting material, the split, amination, reduction, cyclization, salt of palonosetron hydrochloride granisetron.  

  • Write your message here and send it to us